Avidity Biosciences Inc’s filing revealed that its Chief Human Resources Officer McCarthy Teresa unloaded Company’s shares for reported $0.58 million on Sep 23 ’24. In the deal valued at $44.00 per share,13,153 shares were sold. As a result of this transaction, McCarthy Teresa now holds 69,018 shares worth roughly $3.17 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Flanagan W. Michael sold 25,000 shares, generating $1,098,733 in total proceeds. Upon selling the shares at $43.95, the CSTO now owns 72,718 shares.
Before that, Boyce Sarah sold 32,880 shares. Avidity Biosciences Inc shares valued at $1,446,723 were divested by the President and CEO at a price of $44.00 per share. As a result of the transaction, Boyce Sarah now holds 234,663 shares, worth roughly $10.78 million.
Goldman initiated its Avidity Biosciences Inc [RNA] rating to a Buy in a research note published on September 24, 2024; the price target was $59. A number of analysts have revised their coverage, including Barclays’s analysts, who began to cover the stock in late August with a ‘”an Overweight”‘ rating. BofA Securities began covering RNA with “Buy” recommendation on May 03, 2024. Cantor Fitzgerald started covering the stock on March 14, 2024. It rated RNA as “an Overweight”.
Price Performance Review of RNA
On Monday, Avidity Biosciences Inc [NASDAQ:RNA] saw its stock jump 8.50% to $45.93. Over the last five days, the stock has gained 5.59%. Avidity Biosciences Inc shares have risen nearly 407.51% since the year began. Nevertheless, the stocks have risen 600.15% over the past one year. While a 52-week high of $48.80 was reached on 07/29/24, a 52-week low of $4.82 was recorded on 01/02/24. SMA at 50 days reached $43.66, while 200 days put it at $28.24.
Levels Of Support And Resistance For RNA Stock
The 24-hour chart illustrates a support level at 43.17, which if violated will result in even more drops to 40.41. On the upside, there is a resistance level at 47.52. A further resistance level may holdings at 49.11. The Relative Strength Index (RSI) on the 14-day chart is 57.88, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.18, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 14.05%. Stochastics %K at 51.80% indicates the stock is a holding.
How much short interest is there in Avidity Biosciences Inc?
A steep rise in short interest was recorded in Avidity Biosciences Inc stocks on 2024-09-13, dropping by -0.94 million shares to a total of 11.98 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-15 was 12.92 million shares. There was a decline of -7.84%, which implies that there is a negative sentiment for the stock.
